Showing 1 - 10 of 52
Persistent link: https://www.econbiz.de/10003777301
Persistent link: https://www.econbiz.de/10003602401
Persistent link: https://www.econbiz.de/10007641675
There is increasing concern that overlapping patents in the field of genetics will create a costly and legally complex situation known as a patent thicket, which, along with the associated issues of accumulating royalty payments, can act as a disincentive for innovation. One potential means of...
Persistent link: https://www.econbiz.de/10013009585
Open innovation is the subject of increased scholarly debate. A lot of attention has thereby been paid to firm-centered open innovation, characterized by a for-profit motive and the interplay between patents and contracts, resulting in restricted openness. Inspired by the increasing call for...
Persistent link: https://www.econbiz.de/10013010074
Concerns have been raised that the upsurge of 3D printing technology would disrupt the patent system. The central question the present paper aims to address is whether and to what extent the emergence of 3D printing technology indeed urges us to rethink patent law. The paper splits up this...
Persistent link: https://www.econbiz.de/10012957619
While the traditional literature and the policy statements concerning standardization as such emphasize the benefits of standardization, the intellectual property and competition law literature and policymaking has been more critical of standardization. Intellectual property is relevant, as the...
Persistent link: https://www.econbiz.de/10013031407
As a framework regulation for innovation markets, the patent system needs to be tailored to the innovation process, which it is supposed to serve, and to the competitive environment, within which it must operate. In order to ensure an efficient functionality of the patent system as an innovation...
Persistent link: https://www.econbiz.de/10012904702
The present paper discusses the decision earlier this year of Judge Robert W. Sweet of the District Court for the Southern District of New York to deny patent protection for isolated human genes and associated diagnostic methods. The case related to genetic tests for familial breast and ovarian...
Persistent link: https://www.econbiz.de/10014187936